My Brother's Flower Cannabis Brand Logo

My Brother's Flower

Data Snapshot: Jun 01, 2026
$100K+

May-2026

Sales

Neutral

Trend

6-Month

20

Product Count

SKUs

$16

Avg Price

19.7%

YoY Sales Change

-32.4%

YoY Price Change

My Brother's Flower Sales

Market Insights Snapshot

My Brother's Flower Historical Sales by Category

My Brother's Flower concentrated 73.26% of May 2026 sales in Pre-Roll, up 61.61% month over month and 104.90% year over year, while Topical fell to 8.11% share with a -22.59% MoM and -52.02% YoY decline. Tincture & Sublingual held 16.67% share with a 14.84% MoM lift despite a -23.68% YoY drop, and Vapor Pens slipped to 1.95% share with -19.57% MoM and -78.29% YoY. Despite an average price decline of -32.41% YoY to $15.997, total brand sales rose 19.74% YoY, indicating unit growth concentrated in Pre-Roll. The pattern implies the brand is pivoting toward value-priced Pre-Roll volume while retrenching in Topical and Vapor Pens, concentrating category risk into a single growth engine.

Within Colorado Pre-Roll, a rank of 19 positions My Brother's Flower mid-pack, with Pre-Roll’s 73.26% mix and 61.61% MoM surge indicating competitive traction but also exposure if growth normalizes. The -23.68% YoY in Tincture & Sublingual alongside a 14.84% MoM uptick signals a potential stabilization lever, whereas Topical’s -22.59% MoM and Vapor Pens’ -19.57% MoM shrink the diversification base. The implication is that share gains hinge on sustaining Pre-Roll velocity at a lower price point while selectively rebuilding Tincture & Sublingual to mitigate the concentration risk reflected by the 8.11% Topical and 1.95% Vapor Pens shares.

May-2026 Rank
Pre-Roll
Tincture & Sublingual
Topical
19
2
5
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Pre-Roll
73.3%
$13.39
+104.9%
+61.6%
Tincture & Sublingual
16.7%
$32.28
-23.7%
+14.8%
Topical
8.1%
$39.91
-52.0%
-22.6%
Vapor Pens
2.0%
$31.66
-78.3%
-19.6%
My Brother's Flower

Competitive Landscape

My Brother's Flower sits at rank #19 in CO Pre-Roll in May 2026, up 18 positions from #37 year over year, and 2 spots higher than #21 in February 2026; this marks a peak rank of #19 in May 2026 and a current position 18 places behind the category leader. While Cali-Blaze holds #1 with a 29.3% YoY sales increase and Seed & Strain Cannabis Co. improved its rank from #5 to #4 alongside 82.1% YoY sales growth, My Brother's Flower’s climb of 18 ranks year over year versus Spectra moving from #10 to #5 with 121.5% YoY sales growth signals that the brand’s rank gains stem more from steady distribution or mix than outsized velocity. The pattern implies that My Brother's Flower is transitioning from lower-tier presence toward mid-tier relevance, but without acceleration comparable to top-5 movers, the current trajectory points to share stabilization near the high teens rather than imminent top-10 entry.

My Brother's Flower market ranking for CO Pre-Roll

My Brother's Flower

Notable Products

Blueberry Kush Infused Pre-Roll (1.5g) posted the largest month-over-month gain at 93.9% to rank 1, while Pineapple Express Infused Pre-Roll (1.5g) climbed 69.6% to rank 2. Tahoe OG Infused Pre-Roll (1.5g) rose 60.8% to rank 3, and Dusk Infused Pre-Roll (1.5g) increased 65.7% to rank 4, whereas Raw Extra Strength Infused Pre-Roll (1.5g) fell 20.2% to rank 9. With five of the top six SKUs in May 2026 coming from Pre-Roll, the mix signals a pivot toward infused Pre-Roll dominance that is outpacing tincture traction.

Within Tincture & Sublingual, CBD/CBN/THC 10:10:1 Dusk Tincture (1000mg CBD, 1000mg CBN, 100mg THC) in rank 7 grew 3.4% and CBD/CBG/THC 10:10:1 Dawn Tincture (1000mg CBD, 1000mg CBG, 100mg THC) in rank 8 inched up 0.6%, while the category’s highest mover still trails the top Pre-Roll ranks 1–4 by at least three positions. The CBD/THC 4:1 Raw Infused Pre-Roll (1.5g) slipped 1.0% to rank 6 as the category’s weakest mover, and the CBD/THC 25:1 Extra Strength Rosin Raw Tincture (2500mg CBD, 100mg THC) entered at rank 10 with $6,315 but no month-over-month baseline. The pattern implies that incremental tincture gains are insufficient against the double-digit Pre-Roll surges, pointing to resource leverage around infused Pre-Rolls while quarantining underperforming sub-lines.

Product
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
May-2026
MoM %
Blueberry Kush Infused Pre-Roll (1.5g)
Pre-Roll
1
1
2
1
1
+93.9%
Pineapple Express Infused Pre-Roll (1.5g)
Pre-Roll
4
2
1
2
2
+69.6%
Tahoe OG Infused Pre-Roll (1.5g)
Pre-Roll
3
2
3
3
3
+60.8%
Dusk Infused Pre-Roll (1.5g)
Pre-Roll
5
3
4
5
4
+65.7%
Dawn Infused Pre-Roll (1.5g)
Pre-Roll
2
4
5
6
5
+37.8%
CBD/THC 4:1 Raw Infused Pre-Roll (1.5g)
Pre-Roll
7
6
7
4
6
-1.0%
CBD/CBN/THC 10:10:1 Dusk Tincture (1000mg CBD, 1000mg CBN, 100mg THC)
Tincture & Sublingual
6
7
6
7
7
+3.4%
CBD/CBG/THC 10:10:1 Dawn Tincture (1000mg CBD, 1000mg CBG, 100mg THC)
Tincture & Sublingual
10
9
8
8
8
+0.6%
Raw Extra Strength Infused Pre-Roll (1.5g)
Pre-Roll
9
5
9
9
9
-20.2%
CBD/THC 25:1 Extra Strength Rosin Raw Tincture (2500mg CBD, 100mg THC)
Tincture & Sublingual
>10
8
10
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market